Recently, BioInformant released an article titled,  “Do You Know the Top 5 iPS Cell Influencers (Right Now)?” In it, we named the five most important thought leaders that are driving therapeutic and commercial progress with induced pluripotent stem cells (iPS cells) right now in 2015. One of the important individuals that we highlighted was Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics.

In response to this article, Ocata Therapeutics released a press release announcing that “Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics has been awarded the honor of iPSC industry influencer by BioInformant, a leading research firm serving the stem cell sector.” [Read more…]